Pink Sheet Podcast: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push
Executive Summary
Editors from the Pink Sheet and Medtech Insight discuss the retirement of Jeff Shuren, PBM executives again appear unscathed after another Capitol Hill appearance, and the growing push to ensure the FDA’s rare pediatric disease priority review voucher program is renewed.
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Cathy Kelly, Interim Editor in Chief Nielsen Hobbs and Medtech Insight Managing Editor Elizabeth Orr discuss the impact of Jeff Shuren’s retirement as director of the US Food and Drug Administration’s Center for Devices and Radiological Health (:35), how pharmacy benefit manager executives continue to survive the ire of members of Congress (10:12), and the FDA’s change of opinion on the rare pediatric disease priority review voucher program and the push to renew it before its fall sunset (20:41).
More On These Topics From The Pink Sheet
-
PBM Execs Stay On Message Amid Growing US Congressional Frustration At Hearing
-
FDA Leadership Changes Tune On Pediatric Priority Review Voucher Benefit
This and other podcasts are available on the Pink Sheet podcast page, as well as the Citeline channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.